Pattern recognition receptors in chronic pain

Mechanisms and therapeutic implications

Jungo Kato, Nilesh M. Agalave, Camilla I. Svensson

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

For the individual, it is vital to promptly detect and recognize a danger that threatens the integrity of the body. Pattern recognition receptors (PRRs) are several classes of protein families originally classified as receptors detecting exogenous pathogens. PRRs are also capable of recognizing molecules released from damaged tissues (damage-associated molecular pattern molecules; DAMPs) and thereby contribute to danger recognition. Importantly, it is now evident that PRRs, such as toll-like receptors (TLRs) and receptors for advanced glycation end products (RAGE), are not only expressed in peripheral immune cells but also present in neurons and glial cells in the nervous system. These PRR-expressing cells work in concert, enabling highly sensitive danger recognition. However, this sensitiveness can act as a double-edged sword. Accumulated evidence has led to the hypothesis that aberrant activation of PRRs may play a crucial role in the pathogenesis of pathological pain. Indeed, numerous studies employing gene deletion or pharmacological inhibition of PRRs successfully reversed or prevented pathological pain in experimental animal models. Furthermore, a number of preclinical studies have shown the therapeutic potential of targeting PRRs for chronic pain. Here, we review the current knowledge regarding the role of PRRs in chronic pain and discuss the promise and challenges of targeting PRRs as a novel therapeutic approach for chronic pain.

Original languageEnglish
Pages (from-to)261-273
Number of pages13
JournalEuropean Journal of Pharmacology
Volume788
DOIs
Publication statusPublished - 2016
Externally publishedYes

Fingerprint

Pattern Recognition Receptors
Chronic Pain
Therapeutics
Pain
Toll-Like Receptors
Gene Deletion
Neuroglia
Nervous System
Animal Models
Pharmacology
Neurons

Keywords

  • Chronic pain
  • DAMPs
  • PRRs
  • RAGE
  • TLR

ASJC Scopus subject areas

  • Pharmacology

Cite this

Pattern recognition receptors in chronic pain : Mechanisms and therapeutic implications. / Kato, Jungo; Agalave, Nilesh M.; Svensson, Camilla I.

In: European Journal of Pharmacology, Vol. 788, 2016, p. 261-273.

Research output: Contribution to journalReview article

@article{2b725815fa33476d84c600fafe8295c4,
title = "Pattern recognition receptors in chronic pain: Mechanisms and therapeutic implications",
abstract = "For the individual, it is vital to promptly detect and recognize a danger that threatens the integrity of the body. Pattern recognition receptors (PRRs) are several classes of protein families originally classified as receptors detecting exogenous pathogens. PRRs are also capable of recognizing molecules released from damaged tissues (damage-associated molecular pattern molecules; DAMPs) and thereby contribute to danger recognition. Importantly, it is now evident that PRRs, such as toll-like receptors (TLRs) and receptors for advanced glycation end products (RAGE), are not only expressed in peripheral immune cells but also present in neurons and glial cells in the nervous system. These PRR-expressing cells work in concert, enabling highly sensitive danger recognition. However, this sensitiveness can act as a double-edged sword. Accumulated evidence has led to the hypothesis that aberrant activation of PRRs may play a crucial role in the pathogenesis of pathological pain. Indeed, numerous studies employing gene deletion or pharmacological inhibition of PRRs successfully reversed or prevented pathological pain in experimental animal models. Furthermore, a number of preclinical studies have shown the therapeutic potential of targeting PRRs for chronic pain. Here, we review the current knowledge regarding the role of PRRs in chronic pain and discuss the promise and challenges of targeting PRRs as a novel therapeutic approach for chronic pain.",
keywords = "Chronic pain, DAMPs, PRRs, RAGE, TLR",
author = "Jungo Kato and Agalave, {Nilesh M.} and Svensson, {Camilla I.}",
year = "2016",
doi = "10.1016/j.ejphar.2016.06.039",
language = "English",
volume = "788",
pages = "261--273",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",

}

TY - JOUR

T1 - Pattern recognition receptors in chronic pain

T2 - Mechanisms and therapeutic implications

AU - Kato, Jungo

AU - Agalave, Nilesh M.

AU - Svensson, Camilla I.

PY - 2016

Y1 - 2016

N2 - For the individual, it is vital to promptly detect and recognize a danger that threatens the integrity of the body. Pattern recognition receptors (PRRs) are several classes of protein families originally classified as receptors detecting exogenous pathogens. PRRs are also capable of recognizing molecules released from damaged tissues (damage-associated molecular pattern molecules; DAMPs) and thereby contribute to danger recognition. Importantly, it is now evident that PRRs, such as toll-like receptors (TLRs) and receptors for advanced glycation end products (RAGE), are not only expressed in peripheral immune cells but also present in neurons and glial cells in the nervous system. These PRR-expressing cells work in concert, enabling highly sensitive danger recognition. However, this sensitiveness can act as a double-edged sword. Accumulated evidence has led to the hypothesis that aberrant activation of PRRs may play a crucial role in the pathogenesis of pathological pain. Indeed, numerous studies employing gene deletion or pharmacological inhibition of PRRs successfully reversed or prevented pathological pain in experimental animal models. Furthermore, a number of preclinical studies have shown the therapeutic potential of targeting PRRs for chronic pain. Here, we review the current knowledge regarding the role of PRRs in chronic pain and discuss the promise and challenges of targeting PRRs as a novel therapeutic approach for chronic pain.

AB - For the individual, it is vital to promptly detect and recognize a danger that threatens the integrity of the body. Pattern recognition receptors (PRRs) are several classes of protein families originally classified as receptors detecting exogenous pathogens. PRRs are also capable of recognizing molecules released from damaged tissues (damage-associated molecular pattern molecules; DAMPs) and thereby contribute to danger recognition. Importantly, it is now evident that PRRs, such as toll-like receptors (TLRs) and receptors for advanced glycation end products (RAGE), are not only expressed in peripheral immune cells but also present in neurons and glial cells in the nervous system. These PRR-expressing cells work in concert, enabling highly sensitive danger recognition. However, this sensitiveness can act as a double-edged sword. Accumulated evidence has led to the hypothesis that aberrant activation of PRRs may play a crucial role in the pathogenesis of pathological pain. Indeed, numerous studies employing gene deletion or pharmacological inhibition of PRRs successfully reversed or prevented pathological pain in experimental animal models. Furthermore, a number of preclinical studies have shown the therapeutic potential of targeting PRRs for chronic pain. Here, we review the current knowledge regarding the role of PRRs in chronic pain and discuss the promise and challenges of targeting PRRs as a novel therapeutic approach for chronic pain.

KW - Chronic pain

KW - DAMPs

KW - PRRs

KW - RAGE

KW - TLR

UR - http://www.scopus.com/inward/record.url?scp=84978086703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978086703&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2016.06.039

DO - 10.1016/j.ejphar.2016.06.039

M3 - Review article

VL - 788

SP - 261

EP - 273

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

ER -